Task: Answer the multiple-choice question.
Question: Which compound exhibits a -54.133% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CCN(CC(=O)NCc1ccc(Cl)cc1)C(=O)CCc1ccccc1O
b Cc1cc(C)nc(Nc2n[nH]c(COc3ccccc3)n2)n1
c CCC1Oc2ccc(C)cc2N(CC(=O)N(Cc2cccnc2)Cc2cccc(F)c2)C1=O
Answer: a. CCN(CC(=O)NCc1ccc(Cl)cc1)C(=O)CCc1ccccc1O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(CC(=O)NCc1ccc(Cl)cc1)C(=O)CCc1ccccc1O
CCN(CC(=O)NCc1ccc(Cl)cc1)C(=O)CCc1ccccc1O
N-[2-[(4-chlorophenyl)methylamino]-2-oxoethyl]-N-ethyl-3-(2-hydroxyphenyl)propanamide